Entities / Company
Masimo.
American healthcare company
- Reports this week
- 0
- Active events
- 2
- Connections
- 56
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
DHR's acquisition of Masimo has been completed, leading to an increase in financial guidance.Well supported4 reports
-
Masimo completed the acquisition of a pathology consumables manufacturer in early June 2026.Some support1 report
-
Delaware law is being applied to corporate governance issues, specifically regarding how it governs the validity of forum clauses in companies like Masimo that operate across state lines including Florida.Some support3 reports
-
The acquisition of Masimo by Danaher has raised concerns regarding existing patent disputes, expanding Danaher's operational scope.Well supported3 reports
-
Financial news reports include HSBC cutting price targets on Danaher shares and corporate transactions involving Masimo.Well supported3 reports
-
Marie Thibault questioned Masimo's outlook, and a competitor announced a new deal with Philips.Some support2 reports1 development inside
-
Masimo appointed Micah Young as CFO to guide the company through strategic transformation, leveraging his background at Deloitte & Touche LLP.Some support1 report
-
Wells Fargo inquired about the impact of tariffs on Masimo, while Masimo responded to a share repurchase query from Mike Matson.Speculative1 report
-
Medtech companies SurModics and Masimo filed Form 8-K reports regarding cyberattacks they are facing.Speculative1 report
-
The Europe Respiratory Care Devices Market is experiencing growth, driven by rising diseases and aging populations, with Masimo noted as a key market participant in regions like Germany and France.Speculative1 report
-
Masimo joined the AHA Innovators’ Network, and Robert A. Harrington served as AHA past president.Speculative1 report
-
Healthcare companies, including UnitedHealth Group, face market decline due to trade tensions and tariff threats on Canadian imports.Some support1 report
-
Baron Health Care Fund highlighted Masimo stock on July 31, 2025.Some support1 report
-
SET, a core monitoring technology, was identified, and Evan Lamb was listed as a media contact for the company.Some support1 report1 development inside
-
Masimo Corporation is based in Irvine, CA.Well supported4 reports
-
Masimo's CEO and CFO reported on August 13, 2025, detailing margin expansion and updated EPS guidance.Some support1 report
-
Apple reintroduced the Blood Oxygen feature on select Apple Watch models, while Masimo filed a lawsuit regarding patent infringement and trade secrets.Some support2 reports
-
FDA expanded clearance for O3 monitoring use by Masimo.Some support2 reports
-
KTVQ, Masimo, and Bio-Techne were featured in Wall Street analysis as investment opportunities on September 2, 2025.Some support2 reports
-
Joe Kiani founded Masimo Corporation and was appointed to the Iradimed Board, where Susi serves as CEO.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Masimo this week
News at the entities that move Masimo most-
FDA StructuralChris Carr, Georgia Attorney General, seeks stricter state laws following FDA warnings about kratom.Moves Masimo
-
Danaher Corporation StructuralMultiple financial firms and individuals bought new stakes or adjusted holdings in Danaher Corporation on October 18, 2026.Moves Masimo
-
Apple Inc. StructuralApple releases the Duo folding phone, while Google competes in the market and Amazon sells accessories.Moves Masimo
-
Delaware StructuralCompanies are targeting markets in Maryland, Delaware, and Florida, while senior living projects are planned in Long Beach.Moves Masimo
-
DHR StructuralBoth medtech giants, DHR and Thermo Fisher Scientific, reversed their guidance concerns today.Moves Masimo
-
Irvine Shared contextZhang, originally from Changsha, has been reported to be living in Irvine.Moves Masimo
Connections
The 8 strongest of 56, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Transactional
Masimo delisted its common stock from the Nasdaq exchange.
-
FDA Structural
The FDA acts as the regulatory gatekeeper, granting necessary clearances for Masimo's patient monitoring technologies to enter the market.
-
Danaher Corporation Structural
Danaher Corporation is the parent company of Masimo, having acquired it as a wholly owned subsidiary.
-
Apple Inc. Structural
Apple relies on Masimo's pulse oximetry technology for the Apple Watch, while simultaneously engaging in patent infringement litigation.
-
DHR Structural
Danaher acquired Masimo and integrated it as a standalone business unit within its Diagnostics segment.
-
Delaware Structural
Delaware's corporate laws and court system govern Masimo's corporate structure and legal precedents.
-
Irvine Shared context
Masimo is headquartered and operates in Irvine, California.
-
Meta Mentioned together
The provided evidence does not describe any relationship between Meta and Masimo.
History
Events by the month they beganOctober 2026
1 eventAugust 2026
2 eventsJuly 2026
3 events- DHR's acquisition of Masimo has been completed, leading to an increase in financial guidance.
- Masimo completed the acquisition of a pathology consumables manufacturer in early June 2026.
- Delaware law is being applied to corporate governance issues, specifically regarding how it governs the validity of forum clauses in companies like Masimo that operate across state lines including Florida.
Show 1 earlier month
June 2026
18 events- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
- The acquisition of Masimo by Danaher has raised concerns regarding existing patent disputes, expanding Danaher's operational scope.
- Financial news reports include HSBC cutting price targets on Danaher shares and corporate transactions involving Masimo.
- Marie Thibault questioned Masimo's outlook, and a competitor announced a new deal with Philips.
- Masimo appointed Micah Young as CFO to guide the company through strategic transformation, leveraging his background at Deloitte & Touche LLP.
- Wells Fargo inquired about the impact of tariffs on Masimo, while Masimo responded to a share repurchase query from Mike Matson.
- Medtech companies SurModics and Masimo filed Form 8-K reports regarding cyberattacks they are facing.
- The Europe Respiratory Care Devices Market is experiencing growth, driven by rising diseases and aging populations, with Masimo noted as a key market participant in regions like Germany and France.
- Masimo joined the AHA Innovators’ Network, and Robert A. Harrington served as AHA past president.
- Healthcare companies, including UnitedHealth Group, face market decline due to trade tensions and tariff threats on Canadian imports.
- Baron Health Care Fund highlighted Masimo stock on July 31, 2025.
- SET, a core monitoring technology, was identified, and Evan Lamb was listed as a media contact for the company.
- Masimo Corporation is based in Irvine, CA.
- Masimo's CEO and CFO reported on August 13, 2025, detailing margin expansion and updated EPS guidance.
- Apple reintroduced the Blood Oxygen feature on select Apple Watch models, while Masimo filed a lawsuit regarding patent infringement and trade secrets.
- FDA expanded clearance for O3 monitoring use by Masimo.
- KTVQ, Masimo, and Bio-Techne were featured in Wall Street analysis as investment opportunities on September 2, 2025.
- Joe Kiani founded Masimo Corporation and was appointed to the Iradimed Board, where Susi serves as CEO.